Patent ID: 7803548

Claim:
A method of determining the cystic fibrosis status of a human comprising: (a) determining the presence or absence of the 1484G->T mutation in both alleles of the cystic fibrosis transmembrane regulatory (CFTR) gene in a nucleic acid sample obtained from the human, and (b) identifying the human (i) as having cystic fibrosis or being predisposed to cystic fibrosis when the human is homozygous for the 1484G->T mutation in the CFTR gene, or (ii) as being a cystic fibrosis carrier when the human is heterozygous for the 1484G->T mutation in the CFTR gene, or (iii) as having no predisposition or carrier status caused by the 1484G->T mutation when the 1484G->T mutation is absent from both alleles of the CFTR gene.